摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 1-(4-fluorophenyl)-4-(methylthio)-2-[4-(methylthio)phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylate | 812692-25-4

中文名称
——
中文别名
——
英文名称
ethyl 1-(4-fluorophenyl)-4-(methylthio)-2-[4-(methylthio)phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylate
英文别名
ethyl 1-(4-fluorophenyl)-4-methylsulfanyl-2-(4-methylsulfanylphenyl)-6-oxopyrimidine-5-carboxylate
ethyl 1-(4-fluorophenyl)-4-(methylthio)-2-[4-(methylthio)phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylate化学式
CAS
812692-25-4
化学式
C21H19FN2O3S2
mdl
——
分子量
430.524
InChiKey
CHMOYJGJMQBFJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    29
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    110
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Novel pyrimidon derivatives
    申请人:Orchid Chemical & Pharmaceuticals Limited
    公开号:US20040259891A1
    公开(公告)日:2004-12-23
    The present invention relates to novel pyrimidones of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly novel pyrimidones of the general formula (I). 1
    本发明涉及一种新的嘧啶酮,其通式为(I),它们的衍生物、类似物、互变异构体、立体异构体、多晶形态、水合物、溶剂合物、药用盐及含有它们的药用成分。本发明更具体地涉及通式(I)的新嘧啶酮。
  • Pyrimidone derivatives
    申请人:Bexel Pharmaceuticals Inc.
    公开号:US07365069B2
    公开(公告)日:2008-04-29
    The present invention relates to novel pyrimidones of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly novel pyrimidones of the general formula (I)
    本发明涉及一种新的嘧啶酮,其一般式为(I),其衍生物,类似物,互变异构体,立体异构体,多晶形态,水合物,溶剂化物,药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体地涉及一种新的嘧啶酮,其一般式为(I)。
  • US7365069B2
    申请人:——
    公开号:US7365069B2
    公开(公告)日:2008-04-29
查看更多